AI Trend Insights
Evidence-led trend reports that connect public signals to practical tools and product decisions.
finance decision
CBL & ASSOCIATES PROPERTIES INC Posts Higher Revenue and Profit Across Both Windows in Interim Filing
CBL & ASSOCIATES PROPERTIES INC filed the periodic report summarised below from its SEC evidence. Revenue from Contract with Customer, Excluding Assessed Tax was $8,254,000 for the six months ended June 30, 2026, up from $7,472,000 a year earlier. Revenues was $292,447,000 for the six months ended June 30, 2026, up from $282,673,000 a year earlier. Net Income (Loss) Attributable to Parent was $92,931,000 for the six months ended June 30, 2026, up from $11,548,000 a year earlier. Earnings Per Share, Diluted was $2.95 per diluted share for the six months ended June 30, 2026, up from $0.35 per diluted share a year earlier. Net Cash Provided by (Used in) Financing Activities was -$135,096,000 for the six months ended June 30, 2026, up from -$147,310,000 a year earlier.
finance decision
Tucows Widens Loss on Both Windows of Interim Filing as Cash Generation Splits From Bottom Line
TUCOWS INC /PA/ filed the periodic report summarised below from its SEC evidence. Net Income (Loss) Attributable to Parent was -$38,578,000 for the six months ended June 30, 2026, down from -$30,770,000 a year earlier. Operating Income (Loss) was -$9,763,000 for the six months ended June 30, 2026, down from -$4,912,000 a year earlier. Earnings Per Share, Diluted was -$3.46 per diluted share for the six months ended June 30, 2026, down from -$2.79 per diluted share a year earlier. Net Cash Provided by (Used in) Financing Activities was $0 for the six months ended June 30, 2026, up from -$2,469,000 a year earlier. Net Cash Provided by (Used in) Investing Activities was -$9,502,000 for the six months ended June 30, 2026, down from $2,518,000 a year earlier.
finance decision
Oruka Therapeutics Interim Filing Shows Deepening Losses on Both Windows, Management Asserts Twelve-Month Liquidity Runway
Oruka Therapeutics, Inc. filed the periodic report summarised below from its SEC evidence. Net Income (Loss) Attributable to Parent was -$73,026,000 for the six months ended June 30, 2026, down from -$45,573,000 a year earlier. Operating Income (Loss) was -$86,541,000 for the six months ended June 30, 2026, down from -$53,515,000 a year earlier. Accretion (Amortization) of Discounts and Premiums, Investments was $1,401,000 for the six months ended June 30, 2026, down from $3,300,000 a year earlier. Net Cash Provided by (Used in) Financing Activities was $703,642,000 for the six months ended June 30, 2026, up from $109,000 a year earlier.
finance decision
Saul Centers Posts Higher Revenue but Lower Net Income on Both Reporting Windows
SAUL CENTERS, INC. filed the periodic report summarised below from its SEC evidence. Revenues was $155,050,000 for the six months ended June 30, 2026, up from $142,690,000 a year earlier. Net Income (Loss) Attributable to Parent was $17,871,000 for the six months ended June 30, 2026, down from $20,519,000 a year earlier. Operating Income (Loss) was $103,642,000 for the six months ended June 30, 2026, up from $96,429,000 a year earlier. Earnings Per Share, Diluted was $0.24 per diluted share for the three months ended June 30, 2026, down from $0.33 per diluted share a year earlier. Net Cash Provided by (Used in) Financing Activities was -$32,553,000 for the six months ended June 30, 2026, down from -$7,406,000 a year earlier.
finance decision
QCR Holdings Posts Higher Profit and EPS on Both Quarterly and Year-to-Date Bases, While Cash Flow Mix Tilts Toward Financing Outflows
QCR HOLDINGS INC filed the periodic report summarised below from its SEC evidence. Net Income (Loss) Attributable to Parent was $69,634,000 for the six months ended June 30, 2026, up from $54,816,000 a year earlier. Earnings Per Share, Diluted was $4.18 per diluted share for the six months ended June 30, 2026, up from $3.22 per diluted share a year earlier. Accretion (Amortization) of Discounts and Premiums, Investments was -$1,065,000 for the six months ended June 30, 2026, down from -$400,000 a year earlier. Amortization of Intangible Assets was $1,012,000 for the six months ended June 30, 2026, down from $1,322,000 a year earlier. Net Cash Provided by (Used in) Financing Activities was -$11,332,000 for the six months ended June 30, 2026, down from $194,416,000 a year earlier.
finance decision
Innodata Posts Higher Revenue, Net Income, and Diluted EPS on Both Windows of the Interim Filing
INNODATA INC filed the periodic report summarised below from its SEC evidence. Revenue from Contract with Customer, Excluding Assessed Tax was $182,238,000 for the six months ended June 30, 2026, up from $116,737,000 a year earlier. Net Income (Loss) Attributable to Parent was $29,310,000 for the six months ended June 30, 2026, up from $15,006,000 a year earlier. Earnings Per Share, Diluted was $0.86 per diluted share for the six months ended June 30, 2026, up from $0.43 per diluted share a year earlier. Net Cash Provided by (Used in) Financing Activities was $9,965,000 for the six months ended June 30, 2026, up from $1,351,000 a year earlier.
finance decision
MannKind Reports Higher Revenue Alongside Profit-to-Loss Swing in Latest Filing
MANNKIND CORP filed the periodic report summarised below from its SEC evidence. Net Income (Loss) Attributable to Parent was -$35,651,000 for the six months ended June 30, 2026, down from $13,826,000 a year earlier, swinging from a prior-year profit to a loss. Operating Income (Loss) was -$2,018,000 for the six months ended June 30, 2026, down from $27,592,000 a year earlier, swinging from a prior-year profit to a loss. Earnings Per Share, Diluted was -$0.12 per diluted share for the six months ended June 30, 2026, down from $0.04 per diluted share a year earlier, swinging from a prior-year profit to a loss.
finance decision
REINSURANCE GROUP OF AMERICA INC Posts Higher Revenue and Net Income in period-ended-2026-06-30 Filing
REINSURANCE GROUP OF AMERICA INC filed the periodic report summarised below from its SEC evidence. Revenues was $13,131,000,000 for the six months ended June 30, 2026, up from $10,859,000,000 a year earlier. Net Income (Loss) Attributable to Parent was $792,000,000 for the six months ended June 30, 2026, up from $466,000,000 a year earlier. Earnings Per Share, Diluted was $11.99 per diluted share for the six months ended June 30, 2026, up from $6.97 per diluted share a year earlier. Net Cash Provided by (Used in) Financing Activities was $3,439,000,000 for the six months ended June 30, 2026, up from $2,607,000,000 a year earlier. Net Cash Provided by (Used in) Investing Activities was -$5,643,000,000 for the six months ended June 30, 2026, down from -$2,872,000,000 a year earlier.
finance decision
USANA HEALTH SCIENCES INC posts lower revenue and a profit-to-loss swing on both windows, partly cushioned by stronger operating cash
USANA HEALTH SCIENCES INC filed the periodic report summarised below from its SEC evidence. Net Income (Loss) Attributable to Parent was -$13,867,000 for the six months ended July 4, 2026, down from $19,057,000 a year earlier, swinging from a prior-year profit to a loss. Operating Income (Loss) was -$6,122,000 for the six months ended July 4, 2026, down from $32,389,000 a year earlier, swinging from a prior-year profit to a loss. Earnings Per Share, Diluted was -$0.75 per diluted share for the six months ended July 4, 2026, down from $1.01 per diluted share a year earlier, swinging from a prior-year profit to a loss.
finance decision
Arena Group Swings to Loss as Revenue and Operating Profit Soften in Interim Filing
Arena Group Holdings, Inc. filed the periodic report summarised below from its SEC evidence. Net Income (Loss) Attributable to Parent was -$2,834,000 for the six months ended June 30, 2026, down from $112,659,000 a year earlier, swinging from a prior-year profit to a loss. Earnings Per Share, Diluted was -$0.06 per diluted share for the six months ended June 30, 2026, down from $2.38 per diluted share a year earlier, swinging from a prior-year profit to a loss. Revenue from Contract with Customer, Excluding Assessed Tax was $42,589,000 for the six months ended June 30, 2026, down from $76,827,000 a year earlier. Operating Income (Loss) was $1,976,000 for the six months ended June 30, 2026, down from $23,774,000 a year earlier.